Steady-State Pharmacokinetics of Amprenavir Coadministered with Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients

The protease inhibitor (PI) ritonavir is used as a strong inhibitor of cytochrome P450 3A4, which boosts the activities of coadministered PIs, resulting in augmented plasma PI levels, simplification of the dosage regimen, and better efficacy against resistant viruses. The objectives of the present o...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Goujard, Cecile, Vincent, Isabelle, Meynard, Jean-Luc, Choudet, Nathalie, Bollens, Diane, Rousseau, Cyril, Demarles, Didier, Gillotin, Catherine, Bidault, Roselyne, Taburet, Anne-Marie
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2003
Matèries:	Pharmacology
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC148948/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12499178/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.1.118-123.2003
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!